Loan Agreement between Propanc Biopharma Inc. and Paul Mazor dated June 5, 2024
Propanc Biopharma Inc. has received a loan of AUD 100,000 from Paul Mazor. The loan has a term of one year, but Propanc may repay it earlier at its discretion. The loan carries an annual interest rate of 12%. The agreement is effective as of June 5, 2024, and is approved by both parties. This document outlines the key terms and confirms the acceptance and receipt of the funds.
Exhibit 4.2
| To: | Mr. Paul Mazor |
| CC: | Mr. Josef Zelinger |
| From: | Mr. James Nathanielsz |
| Subject: | Loan to Propanc Biopharma Inc. |
Dear Mr. Mazor,
The Board of Directors at Propanc Biopharma Inc. (“Propanc’’) confirm acceptance and receipt of funds for the sum of one hundred thousand Australian dollars (AUD 100,000) from Paul Mazor (the “lender’’) of Apt 2903, 389/1413 The Peak Towers, M. Kasetsin 9 Rd. Nong Prue, Banglamuang, Chonburi, Thailand 20150 (“address’’).
The loan to Propanc is subject to the following terms & conditions:
| ● | Amount: A$100,000.00 | |
| ● | Term: 1 year or earlier at the discretion of the borrower. | |
| ● | Commencement date: 05 June 2024 | |
| ● | Interest rate: 12% pa |
Sincerely,
James Nathanielsz
Chief Executive Officer
Approved by,
Dr Julian Kenyon
Director
Approved by,
Mr Paul Mazor
Investor
p: +61 (0)3 9882 0780 a: 302/6 Butler Street, Camberwell, VIC 3124, AUSTRALIA w: www.propanc.com
